Naproxen and Cromolyn as New Glycogen Synthase Kinase 3β Inhibitors for Amelioration of Diabetes and Obesity: An Investigation by Docking Simulation and Subsequent In Vitro/In Vivo Biochemical Evaluation

  • NAPROXEN AND CROMOLYN AS NEW GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
  • Tarek M. K. Motawi, Yasser Bustanji, Shohda A. EL-Maraghy, Mutasem O. Taha, Mohamed A. S. Al Ghussein
  • Journal of Biochemical and Molecular Toxicology, June 2013, Wiley
  • DOI: 10.1002/jbt.21503

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/jbt.21503

The following have contributed to this page: Professor Tarek Kamal Metawie and Dr Mohamed A S Al Ghussein